Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:1738-1743
Published online before print March 24, 2003, doi: 10.1161/01.CIR.0000060542.79482.81
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/13/1738    most recent
01.CIR.0000060542.79482.81v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagel, E.
Right arrow Articles by Fleck, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagel, E.
Right arrow Articles by Fleck, E.
Related Collections
Right arrow Restenosis
Right arrow Catheter-based coronary interventions: stents
Right arrow Coronary imaging: angiography/ultrasound/Doppler/CC
Right arrow CT and MRI

(Circulation. 2003;107:1738.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Noninvasive Determination of Coronary Blood Flow Velocity With Cardiovascular Magnetic Resonance in Patients After Stent Deployment

Eike Nagel, MD; Thomas Thouet; Christoph Klein, MD; Simon Schalla, MD; Axel Bornstedt, PhD; Bernhard Schnackenburg, PhD; Jürgen Hug, MD; Ernst Wellnhofer, MD; Eckart Fleck, MD

From the Department of Internal Medicine/Cardiology, German Heart Institute, Berlin, and Philips Medical Systems (B.S.), Hamburg, Germany.

Correspondence to Eike Nagel, MD, Internal Medicine/Cardiology, German Heart Institute, Augustenburger Platz 1, D-13353 Berlin, Germany. E-mail eike.nagel{at}dhzb.de


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— In patients with coronary artery stents, no direct noninvasive coronary artery imaging is possible with magnetic resonance (MR). A well-established method for the assessment of the functional significance of a coronary lesion is the measurement of coronary flow reserve by invasive intracoronary Doppler. The purpose of the study was to determine coronary flow velocity reserve (CFVR) with MR after stent deployment.

Methods and Results— Thirty-eight patients after successful PTCA and stent deployment were included. CFVR was measured perpendicular to the artery distal to the stent using phase-contrast velocity quantification at rest and during adenosine-stimulated hyperemia with a 1.5T MR tomograph (ACS NT, Philips). Measurements were repeated after 3 months and compared with invasive coronary angiography. In 18 patients, additional invasive Doppler flow measurements were obtained. CFVR could be determined in 29 of 38 (76%) of the patients. After 3 months, significant differences were obtained between coronary arteries with and without restenosis. Using a threshold of 1.2, a sensitivity of 83% with a specificity of 94% was achieved for >=75% stenoses. CFVR with CMR was similar to Doppler results (r=0.87), with a mean relative difference of 7.5%.

Conclusions— In patients with preserved coronary microcirculating vasoreactivity that are suitable for MR coronary angiography and flow assessments, CMR measures of coronary blood flow velocities reserve may be used to detect in-stent restenosis.


Key Words: magnetic resonance imaging • coronary disease • angiography • restenosis


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Even though stents do not prohibit cardiovascular magnetic resonance (MR) examinations at 1.5 Tesla,1 no direct visualization of the coronary arteries is possible after stent placement because of artifacts induced by the metallic stents.2 In these patients, an assessment of the stents may be possible with the direct determination of coronary artery blood flow velocities using MR flow measurements. Such measurements would not only serve to determine whether an in-stent restenosis has occurred but also to assess its hemodynamic relevance.

The aims of the present study were to evaluate the feasibility of MR phase-contrast flow measurements for the noninvasive assessment of intracoronary blood flow velocity reserve after stent deployment, to determine its accuracy for the detection of restenosis, and to compare the results to invasive Doppler flow measurements.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Patients
After approval of the study from the institutional review committee, 38 patients (29 males and 9 females, age 63±10 years) with clinically indicated stent deployment in the left anterior descending coronary artery (LAD) or the right coronary artery (RCA) were prospectively included in the study after obtaining informed consent. Patients with diabetes, cardiac arrhythmias, left ventricular hypertrophy, and previous myocardial infarction or wall motion abnormalities at rest were excluded from the study to guarantee a homogeneous patient population. Patients were ineligible for enrollment if they had a contraindication for adenosine (heart block or reactive respiratory disease) or MR (pacemaker, intracranial metal, claustrophobia, or obesity >150 kg) or were medically unstable.

Coronary Angiography
All patients underwent biplane left-sided cardiac catheterization and selective coronary angiography in Judkin’s technique before and after stent deployment as well as after 3 months, as routinely done in our institution. Coronary stenoses were filmed in the center of the field from multiple projections, avoiding as much as possible overlap of side branches and foreshortening of relevant coronary stenoses. Quantitative assessment was performed using quantitative coronary angiography (QANSAD QCA System; ARRI Munich) by an experienced observer blinded to the results of the MR examination. Coronary arteries were graded as having a 50% to 74% cross-sectional area reduction or a >=75% cross-sectional area reduction with respect to prestenotic segment area.

Invasive Doppler Flow Measurements
In 18 patients, peak flow velocity measurements were obtained using a 0.014-inch Doppler velocity wire (Cardiometrics) during follow-up angiography. The wire was positioned 10 mm distal to the stent, and measurements were obtained at rest and during adenosine infusion of 0.14 mg/kg body weight per min via an antecubital vein for a maximum of 6 minutes. Coronary flow velocity reserve (CFVR) was calculated as the ratio of peak flow velocity during maximal hyperemia to baseline peak flow velocity.

Magnetic Resonance Flow Measurements
Image Acquisition
Patients were examined with a 1.5-Tesla whole-body MR tomograph (ACS NT, Philips) using a dedicated phased-array cardiac surface coil (5 elements) 24 hours and 3 months after stent deployment. After a rapid survey, transversal slices were acquired in breath hold technique during expiration to localize the coronary arteries. In these images, the position of the stent could be easily determined because of the artifacts induced by the stents. Double-angulated slices, which included a long segment of the vessel, were acquired (Figure 1). In vitro measurements of stent artifacts yielded a maximal artifact size exceeding stent size by 10 mm (5 mm each side).1 In vitro measurements in our institution showed that flow measurements should not be influenced if their distance to the stent doubles the distance of the visible artifact. Thus, measurements were performed perpendicular to the vessel, 5 mm distal to the stent artifact (Figure 1) at rest and during an adenosine-induced hyperemia, applying the identical stress protocol as for the invasive procedure. This position should be very close to the position of the invasive Doppler measurements, because it is well defined by the stent position.



View larger version (86K):
[in this window]
[in a new window]
 
Figure 1. A, Determination of measurement position. An anatomical image parallel to the stent was acquired. The flow measurement was then planned 5 mm distal to the stent artifact perpendicular to the coronary artery. Rest (B) and stress (C) phase-contrast image of a RCA. The flow signal can be clearly seen (rectangles). The bottom row shows a zoomed part of the image at rest (left) and during adenosine stimulation (right), resulting in a coronary flow velocity reserve of 2.16. The white boxes delineate the 4 voxels with the fastest flow velocity.

A segmented k-space phase-contrast turbo gradient echo technique with symmetric bipolar gradient pulses3 with a spatial resolution of 1x0.9x4 mm and a temporal resolution of 45 ms (TE/TR/flip: 6.9 ms/11.5 ms/40°; 4 k-lines per phase per heartbeat; velocity encoding: 100 cm/s at rest and 200 cm/s during stress) was used. To improve signal to noise ratio, 2 acquisitions were performed and the resulting signal was averaged. Breathing artifacts were reduced by prospective navigator gating with adaptive motion correction (gating window: 5 mm). The imaging sequence was adapted to the actual diaphragmatic position in real time. This correction was performed by shifting the craniocaudal imaging position by 30% of the actual diaphragmatic offset.4

Image Analysis
Readers blinded to each technique performed analysis of the MR images and Doppler results. Regions of interest with an area of 2x2 voxels were placed in the center of the vessel on the flow images for each cardiac phase. The region of interest was shifted in each phase to include the 4 voxels with the fastest average flow velocity. The average flow velocity (cm/s) of this region of interest was determined for each phase. To correct for cardiac through plane motion and eddy currents, a region of interest was placed on adjacent myocardium and the velocity of myocardial through plane motion was determined and subtracted from the intracoronary flow values. The highest value was used for the determination of peak flow velocity. CFVR was calculated as the ratio of peak flow velocity during hyperemia to the peak flow velocity at rest. For the assessment of diagnostic accuracy for the detection of stenoses >=75% cross-sectional area reduction, a threshold value of 1.5 was used.

Statistical Analysis
All data are given as mean±1 SD. ANOVA was used to detect differences between groups of different stenosis severity. Significance was tested with a Scheffé procedure. A 2-tailed Student’s t test was used to calculate statistical differences, with P<0.05 being regarded as statistically significant. Comparison between results from Doppler and CMR was performed using the Bland-Altman analysis and a linear regression analysis.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Patient characteristics and hemodynamic data are listed in Tables 1 and 2.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Patient Characteristics


View this table:
[in this window]
[in a new window]
 
TABLE 2. Hemodynamic Data

Invasive Procedures
Stent placement was successfully performed in 25 LAD and 13 RCA vessels ranging from 1.40 to 3.9 mm distal reference diameter (mean, 2.50 mm). At 3 months of follow-up, 14 vessels (37%) showed a restenosis of >=75% cross-sectional area reduction in the invasive coronary angiography. Ten vessels (26%) showed a 50% to 74% cross-sectional area reduction.

MR Measurements
In 29 of the 38 patients (76%), adequate flow measurements could be obtained distal to the stent. In 4 patients no adequate placement of the imaging plane without a major vessel branch leaving the target vessel could be obtained, in 4 patients image quality did not allow to detect a flow signal, and in 1 patient severe shortness of breath developed during adenosine infusion. Examination time was {approx}45 to 60 minutes (3 to 5 minutes for each flow measurement depending on navigator efficiency).

Maximal flow velocity at rest was 66±13 cm/s (LAD) and 37±9 cm/s (RCA). During adenosine stimulation, maximal flow velocity was 121±30 cm/s (LAD) and 70±15 cm/s (RCA), resulting in a mean CFVR of 1.82±0.22 (LAD) and 1.90±0.4 (RCA) (Figure 1).

At follow-up, CFVR of 1.78±0.16 was found in vessels without coronary artery stenosis, 1.46±0.22 in vessels with 50% to 74% cross-sectional area reduction, and 1.10±0.22 in vessels with >=75% cross-sectional area reduction (P between all groups <0.05).

The diagnostic accuracy of CFVR measurements is shown in Table 3. No overlap was found between vessels without (<50% cross-sectional area reduction) and vessels with >=75% cross-sectional area reduction; however, vessels with 50% to 74% cross-sectional area reduction showed overlap with both other groups (Figure 2).


View this table:
[in this window]
[in a new window]
 
TABLE 3. Diagnostic Value of Coronary Flow Velocity Reserve for the Detection of 50% Cross-Sectional Area Reduction and 75% Cross-Sectional Area Reduction



View larger version (12K):
[in this window]
[in a new window]
 
Figure 2. Scattergram of MR coronary flow velocity reserve for different severities of coronary artery stenoses.

Comparison of MR and Doppler
Flow velocity measurements with the Doppler flow wire resulted in 79±20 cm/s (LAD) and 40±6 cm/s (RCA). After adenosine stimulation, flow velocities were 147±36 cm/s (LAD) and 80±21 cm/s (RCA), resulting in a mean CFVR of 1.88±0.25 (LAD) and 2.0±0.48 (RCA).

Regression analysis for CFVR determined with CMR and Doppler resulted in a slope of 0.74 (r=0.89) at rest and 0.80 (r=0.93) during stress (Bland-Altman analysis in Figure 4). For CFVR, the correlation yielded a slope of 1.04 (r=0.87) (Bland-Altman analysis in Figure 3). The mean relative error of MR CFVR measurements versus Doppler was 7.5±5.0%.



View larger version (9K):
[in this window]
[in a new window]
 
Figure 3. Bland-Altman analysis of MR peak flow velocity and intracoronary Doppler flow velocity at rest (A) and stress (B) as well as MR coronary flow velocity reserve and intracoronary Doppler flow velocity reserve (C).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The present study demonstrates that the determination of coronary blood flow velocity and coronary flow velocity reserve with CMR is feasible after stent placement, and the results for CFVR are similar to results from invasive Doppler measurements.

In-stent restenoses are a major problem, and innumerable attempts have been suggested to avoid this drawback. Because all noninvasive tests, such as ECG,5 SPECT,6 or EBCT,7 are relatively insensitive and nonspecific for the detection of restenoses, many of these patients undergo invasive coronary angiography to identify restenosis in recurrent chest pain. In some centers, invasive routine follow-up is performed after stent placement to be able to treat restenosis at an early time point. With CMR, the noninvasive imaging of the proximal and medial coronary arteries becomes more and more feasible; however, the artifacts after stent placement prohibit CMR imaging within the stent. It has been shown to be safe and feasible to measure flow {approx}1 cm distal to the stent using phase-contrast techniques,8,9 which have been well established and validated for larger vessels.10–12 Good accuracy and reproducibility of MR flow measurements have also been shown in small-caliber phantoms or coronary arteries in animals,13–15 with close correlations with intravascular and extravascular Doppler techniques despite the complexity of such measurements in small and rapidly moving vessels. Previous investigators have used breath hold techniques to reduce breathing artifacts, which limits the maximal scan duration to 30 seconds or less.16–20 Whereas with this approach data can be acquired rapidly and breathing motion artifacts can be well suppressed, a low temporal resolution has to be accepted. Accordingly, in these previous studies the number of heart phases ranged from 1 to 621 and was only increased by calculating interleaved data (view sharing).22 In 1993, Edelman et al16 demonstrated for the first time that blood flow velocity can be determined noninvasively in human coronary arteries with MR; however, only a single middiastolic value was obtained. In an animal study, Clarke et al23 were able to demonstrate that an increase of the temporal resolution from 1 to 6 frames per heartbeat led to a reduction of the limits of agreement between MR and Doppler from 45 to 10 mL/min. However, no additional improvement of temporal resolution was tested at that time to avoid overly long breath holding. Since then, the technique has been additionally optimized and compared with invasive measurements of flow or flow reserve.17,19,21,24,25 Hundley et al26 have shown a sensitivity and specificity of 100% and 83% for the detection of significant coronary artery stenoses of the proximal and middle left anterior descending coronary artery using a breath hold technique with a temporal resolution of 112 to 168 ms. In another study of 17 patients, using the same technique they showed that in patients with recurrent chest pain 6 weeks after a successful percutaneous intervention (8 with stent deployment), the assessment of flow reserve with phase-contrast CMR can be used to identify a 70% luminal diameter narrowing at the site of the intervention (sensitivity 100%; specificity 89%) compared with QCA.27 In this study, however, an inhomogeneous patient population was included, eg, a large percentage of patients with myocardial infarction or hypertension. In addition, only patients with proximal and middle left coronary artery disease and 1 patient with right coronary artery disease were included. Especially in the right coronary artery, rapid in-plane motion is to be expected, and a temporal resolution below 25 ms is required to accurately measure coronary artery flow in the RCA with MR methods.28 Because the breath hold techniques applied in previous studies resulted in a temporal resolution of <100 ms, the investigators limited themselves to the LAD, except for 1 reported case of flow measurements in the RCA.17,19,26,27 With this study we extend MR flow measurements to the RCA, which was possible by using shorter acquisition times per heartbeat. Even though we did not reach the temporal resolution set forth by Hofman et al,28 we were able to come very close to this value, thus minimizing motion-induced blurring and inaccuracies. A second advantage of the navigator-gating technique used is the elimination of the need of breath holding for up to 30 seconds. Such breath holds are difficult for many patients, especially with adenosine stimulation, and may influence coronary artery flow due to the Valsalva maneuver.

This study extends previous observations in several aspects. First, we concentrated on a subgroup of patients, which presents a major problem for optimal treatment and follow-up, namely patients after stent deployment. In this group, noninvasive visualization of the coronary arteries with MR or CT imaging is not possible in the stented segments. From a methodological view, MR coronary flow measurements are more difficult in this group, because the exact coronary segment for flow measurements is predefined by the stent, not by the MR examiner. This predefined measurement position, however, allows a more accurate comparison of MR and Doppler flow wire. Second, we included patients with stents in the left or right coronary artery, thus extending the potential application of MR flow measurements. Third, the position of the flow measurement was not predefined by the inclusion criteria but by the clinical decision on where to place the stent. Thus, the present study covers the full range of vessel diameters usually stented in clinical practice from 1.4 to 3.9 mm.

In the present study, we show that an in-stent coronary artery cross-sectional area reduction of >=50% can be detected with an accuracy of 86% and a high positive predictive value of 94%. For cross-sectional area reductions of >=75%, a diagnostic accuracy of 90% was reached. The slightly reduced sensitivity of 85% for the detection of 50% area reduction may reflect the fact that flow does not measure morphology but function and such luminal area reductions may not have any hemodynamic relevance in some cases.

With CMR, an underestimation of coronary flow velocity was found compared with Doppler. This observation has also been reported from other authors.19,29,30 It can be mainly attributed to the lower temporal resolution (and, thus, the highest flow velocity during the cardiac cycle is missed) and the lower spatial resolution (and, thus, an average flow velocity of a small region of interest, rather than the fastest flow velocity within the vessel, is determined) compared with intravascular Doppler. However, underestimation was systematic and thus can be corrected for. In addition, the calculation of flow velocity reserve rather than the use of absolute values led to similar results for CMR and Doppler.

Mild but significantly higher heart rates were found during the MR stress study in comparison with the Doppler examination. Because exactly the same stress protocol was used for both examinations, this can either be explained by psychological reasons (with the patient more stressed within the MR scanner, leading to a tendency of higher heart rates at rest) or the fact that the MR scan was done before the invasive procedure and, thus, the patient was more accustomed to adenosine during the invasive measurement. However, the mean difference was 5 beats per minute, which should only have a very limited influence on coronary artery flow.

Limitations
A general limitation applies to the concept of coronary flow reserve measurements, because these measurements are not applicable to patients with abnormal coronary flow at rest. This includes patients with myocardial infarction, left ventricular hypertrophy, microvessel disease, cardiomyopathy, or severe valvular heart disease or patients in the first weeks after coronary intervention or after bypass grafting. In our study, these patients were excluded.

A technical limitation applies to the technique used. To achieve high spatial and temporal resolution, long scan times of 3 to 5 minutes for each flow measurement, depending on navigator efficiency, were accepted, which prohibited the assessment of more than one coronary artery during one adenosine stress, because this stress test is limited to a maximum duration of 6 minutes. In addition, planning of image acquisition and image analysis required >2 hours, which prohibited the routine clinical use of the technique at the current time.

Conclusions
In conclusion, MR flow measurements allow the noninvasive determination of coronary blood flow velocities after stent deployment similar to Doppler flow measurements. This technique can be used to detect in-stent restenosis with a diagnostic accuracy of 86% for >=50% cross-sectional area reduction and 90% for >=75% cross-sectional area reduction in patients with preserved vasoreactivity.


*    Footnotes
 
Dr Nager received grant support from Philips Medical Systems, Best, the Netherlands, and Dr Schnackenburg is an employee of Philips Medical Systems, Hamburg, Germany.

Received November 13, 2002; revision received January 16, 2003; accepted January 16, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Hug J, Nagel E, Bornstedt A, et al. Coronary arterial stents: safety and artifacts during MR imaging. Radiology. 2000; 216: 781–787.[Abstract/Free Full Text]
  2. Bartels LW, Smits HF, Bakker CJ, et al. MR imaging of vascular stents: effects of susceptibility, flow, and radiofrequency eddy currents. J Vasc Interv Radiol. 2001; 12: 365–371.[Medline] [Order article via Infotrieve]
  3. Doumoulin C, Souza S, Walker M, et al. Three-dimensional phase contrast angiography. Magn Reson Med. 1989; 9: 139–149.[Medline] [Order article via Infotrieve]
  4. Nagel E, Bornstedt A, Schnackenburg B, et al. Optimization of realtime adaptive navigator correction for 3D magnetic resonance coronary angiography. Magn Reson Med. 1999; 42: 408–411.[CrossRef][Medline] [Order article via Infotrieve]
  5. Honan MB, Bengtson JR, Pryor DB, et al. Exercise treadmill testing is a poor predictor of anatomic restenosis after angioplasty for acute myocardial infarction. Circulation. 1989; 80: 1585–1594.[Abstract/Free Full Text]
  6. DePuey E. Myocardial perfusion imaging with thallium-201 to evaluate patients before and after percutaneous transluminal coronary angioplasty. Circulation. 1991; 84: 59–65.
  7. Achenbach S, Moshage W, Bachmann K. Detection of high-grade restenosis after PTCA using contrast-enhanced electron beam CT. Circulation. 1997; 96: 2785–2788.[Abstract/Free Full Text]
  8. Moran PR. A flow velocity zeugmatographic interlace for NMR imaging in humans. Magn Reson Imaging. 1982; 1: 197–203.[CrossRef][Medline] [Order article via Infotrieve]
  9. Bryant DJ, Payne JA, Firmin DN, et al. Measurement of flow with NMR imaging using a gradient pulse and phase difference technique. J Comput Assist Tomogr. 1984; 8: 588–593.[Medline] [Order article via Infotrieve]
  10. Pelc NJ, Herfkens RJ, Shimakawa A, et al. Phase contrast cine magnetic resonance imaging. Magn Reson Q. 1991; 7: 229–254.[Medline] [Order article via Infotrieve]
  11. Van Rossum AC, Sprenger M, Visser FC, et al. An in vivo validation of quantitative blood flow imaging in arteries and veins using magnetic resonance phase-shift techniques. Eur Heart J. 1991; 12: 117–126.[Abstract/Free Full Text]
  12. Evans AJ, Iwai F, Grist TA, et al. Magnetic resonance imaging of blood flow with a phase subtraction technique: in vitro and in vivo validation. Invest Radiol. 1993; 28: 109–115.[CrossRef][Medline] [Order article via Infotrieve]
  13. Keegan J, Firmin D, Gatehouse P, et al. The application of breath hold phase velocity mapping techniques to the measurement of coronary artery blood flow velocity: phantom data and initial in vivo results. Magn Reson Med. 1994; 31: 526–536.[Medline] [Order article via Infotrieve]
  14. McCauley TR, Pena CS, Holland CK, et al. Validation of volume flow measurements with cine phase-contrast MR imaging for peripheral arterial waveforms. J Magn Reson Imaging. 1995; 5: 663–668.[Medline] [Order article via Infotrieve]
  15. Hofman MB, Visser FC, van Rossum AC, et al. In vivo validation of magnetic resonance blood volume flow measurements with limited spatial resolution in small vessels. Magn Reson Med. 1995; 33: 778–784.[Medline] [Order article via Infotrieve]
  16. Edelman RR, Manning WJ, Gervino E, et al. Flow velocity quantification in human coronary arteries with fast breath-hold MR angiography. J Magn Reson Imaging. 1993; 3: 699–703.[Medline] [Order article via Infotrieve]
  17. Clarke GD, Eckels R, Chaney C, et al. Measurement of absolute epicardial coronary artery flow and flow reserve with breath-hold cine phase-contrast magnetic resonance imaging. Circulation. 1995; 91: 2627–2634.[Abstract/Free Full Text]
  18. Pennell DJ, Firmin DN, Burger P, et al. Assessment of magnetic resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery disease. Br Heart J. 1995; 74: 163–170.[Abstract/Free Full Text]
  19. Hundley WG, Lange RA, Clarke GD, et al. Assessment of coronary arterial flow and flow reserve in humans with magnetic resonance imaging. Circulation. 1996; 93: 1502–1508.[Abstract/Free Full Text]
  20. Hofman MB, van Rossum AC, Sprenger M, et al. Assessment of flow in the right human coronary artery by magnetic resonance phase contrast velocity measurement: effects of cardiac and respiratory motion. Magn Reson Med. 1996; 35: 521–531.[Medline] [Order article via Infotrieve]
  21. Sakuma H, Blake LM, Amidon TM, et al. Coronary flow reserve: noninvasive measurement in humans with breath-hold velocity-encoded cine MR imaging. Radiology. 1996; 198: 745–750.[Abstract/Free Full Text]
  22. Foo TK, Bernstein MA, Aisen AM, et al. Improved ejection fraction and flow velocity estimates with use of view sharing and uniform repetition time excitation with fast cardiac techniques. Radiology. 1995; 195: 471–478.[Abstract/Free Full Text]
  23. Clarke GD, Hundley WG, McColl RW, et al. Velocity-encoded, phase-difference cine MRI measurements of coronary artery flow: dependence of flow accuracy on the number of cine frames. J Magn Reson Imag. 1996; 6: 773–742.
  24. Davis CP, Liu PF, Hauser M, et al. Coronary flow and coronary flow reserve measurements in humans with breath-held magnetic resonance phase contrast velocity mapping. Magn Reson Med. 1997; 37: 537–544.[Medline] [Order article via Infotrieve]
  25. Grist TM, Polzin JA, Bianco JA, et al. Measurement of coronary blood flow and flow reserve using magnetic resonance imaging. Cardiology. 1997; 88: 80–89.[Medline] [Order article via Infotrieve]
  26. Hundley W, Hamilton C, Clarke G, et al. Visualization and functional assessment of proximal and middle left anterior descending coronary stenoses in humans with magnetic resonance imaging. Circulation. 1999; 99: 3248–3254.[Abstract/Free Full Text]
  27. Hundley W, Hillis D, Hamilton C, et al. Assessment of coronary arterial restenosis with phase-contrast magnetic resonance imaging measurements of coronary flow reserve. Circulation. 2001; 101: 2375–2381.
  28. Hofman MB, Wickline SA, Lorenz CH. Quantification of in-plane motion of the coronary arteries during the cardiac cycle: implications for acquisition window duration for MR flow quantification. J Magn Reson Imaging. 1998; 8: 568–76.[Medline] [Order article via Infotrieve]
  29. Shibata M, Sakuma H, Isaka N, et al. Assessment of coronary flow reserve with fast cine phase contrast magnetic resonance imaging: comparison with measurement by Doppler guide wire. J Magn Reson Imaging. 1999; 10: 563–568.[CrossRef][Medline] [Order article via Infotrieve]
  30. Nagel E, Bornstedt A, Hug J, et al. Noninvasive determination of coronary blood flow velocity with magnetic resonance imaging: comparison of breath-hold and navigator techniques with intravascular ultrasound. Magn Reson Med. 1999; 41: 544–549.[CrossRef][Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
CirculationHome page
D. A. Bluemke, S. Achenbach, M. Budoff, T. C. Gerber, B. Gersh, L. D. Hillis, W. G. Hundley, W. J. Manning, B. F. Printz, M. Stuber, et al.
Noninvasive Coronary Artery Imaging: Magnetic Resonance Angiography and Multidetector Computed Tomography Angiography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young
Circulation, July 29, 2008; 118(5): 586 - 606.
[Full Text] [PDF]


Home page
CirculationHome page
E. Spuentrup, A. Ruebben, A. Mahnken, M. Stuber, C. Kolker, T. H. Nguyen, R. W. Gunther, and A. Buecker
Artifact-Free Coronary Magnetic Resonance Angiography and Coronary Vessel Wall Imaging in the Presence of a New, Metallic, Coronary Magnetic Resonance Imaging Stent
Circulation, March 1, 2005; 111(8): 1019 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Terashima, C. H. Meyer, B. G. Keeffe, E. J. Putz, E. de la Pena-Almaguer, P. C. Yang, B. S. Hu, D. G. Nishimura, and M. V. McConnell
Noninvasive assessment of coronary vasodilation using magnetic resonance angiography
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 104 - 110.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. R. Moreno and V. Fuster
The year in atherothrombosis
J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2099 - 2110.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. P. Salm, J. J. Bax, H. W. Vliegen, S. E. Langerak, P. Dibbets, J. W. Jukema, H. J. Lamb, E. K.J. Pauwels, A. de Roos, and E. E. van der Wall
Functional significance of stenoses in coronary artery bypass grafts: Evaluation by single-photon emission computed tomography perfusion imaging, cardiovascular magnetic resonance, and angiography
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1877 - 1882.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report
Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/13/1738    most recent
01.CIR.0000060542.79482.81v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagel, E.
Right arrow Articles by Fleck, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagel, E.
Right arrow Articles by Fleck, E.
Related Collections
Right arrow Restenosis
Right arrow Catheter-based coronary interventions: stents
Right arrow Coronary imaging: angiography/ultrasound/Doppler/CC
Right arrow CT and MRI